1Zimmermann M, Gardoni F, Marcello E, et al. Acetylcholinesterase inhibitors increase ADAM 10 activity by promoting its trafficking in neuroblastoma cell lines. J Neurochem, 2004, 90(6): 1489-1499.
2Zimmermann M, Borroni B, Cattabeni F, et al. Cholineslerase inhibitors influence APP metabolism in Alzheimer disease patients.Neurobiol Dis, 2005, 19:237-242.
3Colciaghi F, Borroni B, Zimmermann M, et al. Amylonid precursor protein melabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts. Nenrobiol Dis, 2004, 16(2):454-460.
4Kao SC, Krichevsky AM, Kosik KS, et al. BACEI suppression by RNA interference in primary cortical neurons. J Biol Chem, 2004,279(3): 1942-1949.
5Lanz TA,Hosley JD,Adams WJ,et al.Studies of A βpharmacodynamics in the brain,cerebrospinal fluid,and plasma in young (plaque-free) Tg2576 mice using the τ-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5hdibenzo[b、d]azepin-7-yl]-L-alaninamide(LY-411575).J Pharmacol Exp Ther,2004,309(1):49-55.
6Permanne B. Adessi C, Sabvoio GP, et al. Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease hy Ireatment with a h-sheet breaker peptide FASEB J, 2002, 16: 860-862.
7Leissring MA, Farris W, Chang AY, et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation,secondary pathology, and premature death. Neuron, 2003, 40(6):1087-1093.
8Postina R, Schroeder A, Dewachter 1, et al. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects it. an Alzheimer's disease mouse model. J Cli Invest, 2004, 113(10): 1456-1464.
9Ercheberrigaray R, Tau M, Dewachter I, et al. Therapentic ettects of PKC activators in Alzheimer's disease transgenic mice. Proc Natl Acad Sci USA, 2004, 101(30): 11141-11146.
10Hara H, Monsonego A, Yuasa K, et al. Development of a safe oral A heta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. J Alzheimers Dis, 2004, 6: 483-488.
